Allianz SE
Allianz SE (ALIZY) Financial Performance & Income Statement Overview
Explore the financials of Allianz SE (ALIZY), including yearly and quarterly data on income, cash flow, and balance sheets.
Allianz SE (ALIZY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Allianz SE ALIZY financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $26.93B | $35.93B | $35.43B | $22.63B |
| Cost of Revenue | $6.12B | $6.41B | $0.00 | $0.00 |
| Gross Profit | $20.80B | $29.52B | $35.43B | $22.63B |
| Gross Profit Ratio | $0.77 | $0.82 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $8.40B | $0.00 | $0.00 |
| Operating Expenses | $17.24B | $32.41B | $31.91B | $19.14B |
| Total Costs & Expenses | $23.37B | $41.58B | $31.91B | $19.14B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $190.00M | $204.00M | $192.00M | $0.00 |
| Depreciation & Amortization | $68.00M | $74.00M | $73.00M | $75.00M |
| EBITDA | $3.81B | $3.80B | $3.59B | $3.56B |
| EBITDA Ratio | $0.14 | $0.11 | $0.10 | $0.16 |
| Operating Income | $3.75B | $3.52B | $3.52B | $3.48B |
| Operating Income Ratio | $0.14 | $0.10 | $0.10 | $0.15 |
| Other Income/Expenses (Net) | -$190.00M | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $3.56B | $3.52B | $3.52B | $3.48B |
| Income Before Tax Ratio | $0.13 | $0.10 | $0.10 | $0.15 |
| Income Tax Expense | $974.00M | $883.00M | $910.00M | $823.00M |
| Net Income | $2.42B | $2.47B | $2.47B | $2.51B |
| Net Income Ratio | $0.09 | $0.07 | $0.07 | $0.11 |
| EPS | $6.28 | $6.43 | $6.38 | $6.45 |
| Diluted EPS | $6.27 | $6.40 | $6.38 | $6.45 |
| Weighted Avg Shares Outstanding | $385.90M | $385.85M | $387.33M | $389.35M |
| Weighted Avg Shares Outstanding (Diluted) | $386.00M | $387.81M | $387.39M | $389.49M |
Over the past four quarters, Allianz SE demonstrated steady revenue growth, increasing from $22.63B in Q2 2024 to $26.93B in Q1 2025. Operating income reached $3.75B in Q1 2025, maintaining a consistent 14% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $3.81B, reflecting operational efficiency. Net income dropped to $2.42B, with EPS at $6.28. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan